SOURCE: Cypress Bioscience, Inc.

June 13, 2007 15:04 ET

Cypress Bioscience, Inc. to Present at Needham Biotechnology and Medical Technology Conference

SAN DIEGO, CA--(Marketwire - June 13, 2007) - Cypress Bioscience, Inc. (NASDAQ: CYPB) today announced that Ciara Kennedy, its Director of Strategy and Business Development, will present at the Needham Biotechnology and Medical Technology Conference on Thursday, June 14, 2007.

The Needham conference is being held at the New York Palace Hotel, New York City. Dr. Kennedy is scheduled to present on Thursday, June 14th at 11:00 a.m. Eastern Time.

About Cypress Bioscience, Inc.

Cypress is committed to be the innovator and leader in providing products that improve the treatment of Functional Somatic Syndromes and other central nervous system conditions. Cypress' strategy involves acquiring/in-licensing undervalued central nervous system active compounds and developing them for new indications.

For more information about Cypress, please visit the Company's web site at www.cypressbio.com.

Contact Information

  • For additional information please contact
    For Cypress Bioscience:
    Sabrina Martucci Johnson
    Executive VP, Chief Business Officer and Chief Financial Officer
    Mary Gieson
    Investor Relations
    (858) 452-2323